Molecular Partners AG (SWX:MOLN)

Molecular Partners AG Balance Sheet

Financials in millions CHF. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	82.65	63.87	67.31	87.95	71.81
Short-Term Investments	10.41	85.57	119.58	161.2	61
Cash & Short-Term Investments	93.06	149.44	186.89	249.14	132.81
Cash Growth	-37.73%	-20.04%	-24.99%	87.59%	-23.55%
Accounts Receivable	1.83	2.32	1.95	1.02	25.65
Other Current Assets	1.99	2.53	3.62	4.59	5.73
Total Current Assets	96.88	154.28	192.46	254.75	164.19
Net Property, Plant & Equipment	5.23	4.2	5.68	7.24	8.15
Other Intangible Assets	0	0.05	0.21	0.27	0.33
Total Assets	102.11	158.53	198.35	262.26	172.67
Accounts Payable	1.93	1.86	-	-	-
Accrued Expenses	8.06	7.71	7.55	7.5	9.98
Current Portion of Leases	1.21	1.22	1.21	1.2	1.19
Unearned Revenue	-	-	4.33	10.05	35.24
Total Current Liabilities	11.03	10.79	14.42	17.25	46.87
Long-Term Leases	2.44	1.23	2.44	3.65	4.85
Other Long-Term Liabilities	8.15	4.88	6.39	4.7	14.13
Total Long-Term Liabilities	10.75	6.11	7.51	9.84	18.51
Total Liabilities	21.77	16.89	21.92	27.09	65.38
Common Stock	4.04	4.04	3.64	3.6	3.23
Treasury Stock	-1.13	-0.98	-0.98	-0.98	-
Additional Paid-in Capital	389.18	384.88	365.53	360.32	355.01
Retained Earnings	-311.75	-246.29	-191.76	-127.78	-250.95
Shareholders' Equity	80.33	141.64	176.43	235.17	107.29
Total Liabilities & Equity	102.11	158.53	198.35	262.26	172.67
Total Debt	3.64	2.44	3.65	4.85	6.04
Net Cash (Debt)	89.41	147	183.24	244.29	126.77
Net Cash Growth	-39.17%	-19.78%	-24.99%	92.70%	-23.86%
Net Cash Per Share	2.40	4.32	5.59	7.34	4.09
Book Value	80.33	141.64	176.43	235.17	107.29
Book Value Per Share	2.16	4.16	5.38	7.07	3.46
Tangible Book Value	80.33	141.59	176.22	234.9	106.96
Tangible Book Value Per Share	2.16	4.16	5.38	7.06	3.45

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.